TW372872B - Thieno[1,5]benzodiazepine use - Google Patents

Thieno[1,5]benzodiazepine use

Info

Publication number
TW372872B
TW372872B TW084105417A TW84105417A TW372872B TW 372872 B TW372872 B TW 372872B TW 084105417 A TW084105417 A TW 084105417A TW 84105417 A TW84105417 A TW 84105417A TW 372872 B TW372872 B TW 372872B
Authority
TW
Taiwan
Prior art keywords
thieno
benzodiazepine
methyl
benzodiazepine use
piperazinyl
Prior art date
Application number
TW084105417A
Other languages
English (en)
Inventor
Beverley Greenwood
David Lloyd Garver Nelson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of TW372872B publication Critical patent/TW372872B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
TW084105417A 1994-06-03 1995-05-29 Thieno[1,5]benzodiazepine use TW372872B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/253,658 US5457101A (en) 1994-06-03 1994-06-03 Thieno[1,5]benzoidiazepine use

Publications (1)

Publication Number Publication Date
TW372872B true TW372872B (en) 1999-11-01

Family

ID=22961179

Family Applications (1)

Application Number Title Priority Date Filing Date
TW084105417A TW372872B (en) 1994-06-03 1995-05-29 Thieno[1,5]benzodiazepine use

Country Status (14)

Country Link
US (1) US5457101A (zh)
EP (1) EP0685233B1 (zh)
JP (1) JPH07330608A (zh)
KR (1) KR960000229A (zh)
CN (1) CN1119101A (zh)
AU (1) AU684924B2 (zh)
CA (1) CA2150517A1 (zh)
DE (1) DE69528109D1 (zh)
HU (1) HUT71598A (zh)
IL (1) IL113912A (zh)
NO (1) NO306977B1 (zh)
NZ (1) NZ272231A (zh)
TW (1) TW372872B (zh)
ZA (1) ZA954358B (zh)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR5278A (es) 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US5981523A (en) * 1996-02-05 1999-11-09 Eli Lilly And Company Compounds and methods for treating multiple sclerosis
JP2000506860A (ja) * 1996-03-11 2000-06-06 イーライ・リリー・アンド・カンパニー 自閉症の処置方法
AU734011B2 (en) * 1996-03-11 2001-05-31 Eli Lilly And Company Method for treating bipolar disorder
CN1494907A (zh) * 1996-03-25 2004-05-12 治疗疼痛的药物组合物
CN1219878A (zh) * 1996-03-25 1999-06-16 伊莱利利公司 治疗疼痛的方法
IL126063A (en) * 1996-03-25 2002-04-21 Lilly Co Eli Medicinal products containing ulanzapine for the treatment of migraine pain
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
US20030022889A1 (en) * 1997-04-15 2003-01-30 Bymaster Franklin P. Method for providing neuro-protective effects
AU6955998A (en) * 1997-04-15 1998-11-11 Eli Lilly And Company Method for providing neuro-protective effects
JP2002530339A (ja) 1998-11-23 2002-09-17 セプラコール， インク． ２−ヒドロキシメチルオランザピン組成物及び方法
US6348455B1 (en) 1998-11-23 2002-02-19 Sepracor Inc. Desmetylolanzapine compositions and methods
WO2000030649A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. Pharmaceutical compositions containing olanzapine-n-oxide
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
US6348458B1 (en) 1999-12-28 2002-02-19 U & I Pharmaceuticals Ltd. Polymorphic forms of olanzapine
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
UA80095C2 (en) * 2001-07-20 2007-08-27 Lilly Co Eli 2 methyl-thieno-benzodiazepine lyophilized formulation and method for the preparation thereof
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
GB0207091D0 (en) * 2002-03-26 2002-05-08 Ml Lab Plc Method of treatment
US7407788B2 (en) * 2002-11-21 2008-08-05 Danisco A/S, Genencor Division BGL7 beta-glucosidase and nucleic acids encoding the same
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
EP1625334B9 (en) 2003-05-21 2012-07-25 Alexza Pharmaceuticals, Inc. Percussively ignited self-contained heating unit
GB0314149D0 (en) * 2003-06-18 2003-07-23 Generics Uk Ltd Novel amorphous forms
US20050272720A1 (en) * 2004-01-27 2005-12-08 Rolf Keltjens Process for making olanzapine Form I
WO2005070938A1 (en) * 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP2353590A1 (en) * 2005-02-15 2011-08-10 Elan Pharma International Limited Aerosol and injectable formulations of nanoparticulate benzodiazepine
WO2007020080A1 (en) * 2005-08-17 2007-02-22 Synthon B.V. A process for making olanzapine form i
WO2007134845A2 (en) * 2006-05-18 2007-11-29 Synthon B.V. Olanzapine pharmaceutical composition
US20080138409A1 (en) * 2006-09-29 2008-06-12 Osinga Niels J Olanzapine pharmaceutical composition
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
WO2012051502A1 (en) 2010-10-14 2012-04-19 University Of Utah Research Foundation Methods and compositions related to neuroactive thiazoline compounds
EP3497105A1 (en) * 2016-08-11 2019-06-19 Eli Lilly And Company Aminothiazines and their use as bace1 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
NZ247703A (en) * 1992-05-29 1995-07-26 Lilly Industries Ltd Thienobenzdiazepine derivatives and medicaments thereof
EP0620222A3 (en) * 1993-04-14 1995-04-12 Lilly Co Eli Tetrahydro-beta-carbolines.
CA2185236A1 (en) * 1994-03-11 1995-09-14 James Edmund Audia Method for treating 5ht2b receptor related conditions

Also Published As

Publication number Publication date
NO306977B1 (no) 2000-01-24
DE69528109D1 (de) 2002-10-17
JPH07330608A (ja) 1995-12-19
NZ272231A (en) 2001-05-25
HU9501600D0 (en) 1995-07-28
ZA954358B (en) 1996-11-29
EP0685233A3 (en) 1996-04-03
EP0685233B1 (en) 2002-09-11
IL113912A0 (en) 1995-08-31
AU2042495A (en) 1995-12-14
EP0685233A2 (en) 1995-12-06
IL113912A (en) 1999-04-11
CA2150517A1 (en) 1995-12-04
NO952130D0 (no) 1995-05-30
CN1119101A (zh) 1996-03-27
KR960000229A (ko) 1996-01-25
US5457101A (en) 1995-10-10
NO952130L (no) 1995-12-04
AU684924B2 (en) 1998-01-08
HUT71598A (en) 1996-01-29

Similar Documents

Publication Publication Date Title
TW372872B (en) Thieno[1,5]benzodiazepine use
AU643267B2 (en) 2-methyl-10-(4-methyl-1-piperazinyl)-4H-thieno(2,3-b)(1,5)- benzodiazepine and process for making the same
HUP9802824A3 (en) Novel crystal form of the 2-methyl-4-(4-methyl-1-piprezinyl)-10h-thieno[2,3-b][1,5]benzodiazepine and process for its preparation
PL337126A1 (en) Novel compounds
CA2263561A1 (en) Thienopyrimidines
IL132967A0 (en) 3-Substituted 3,4-dihydro-thieno¬2,3-d¾pyrimidine derivatives and production and use of the same
ZA904991B (en) 5,11-dihydro-6h-dipyrido(3,2-b:2',3'-e)(1,4)-diazepin-6-ones and-thiones and their use for the treatment of aids
AU4856893A (en) 3,3'-disubstituted-1,3-dihydro-2h-pyrrolo{2,3-b}heterocyclic -2-one useful in the treatment of cognitive disorders of man
NZ332037A (en) Olanzapine for treating migraine pain
TW429149B (en) Pharmaceutical composition for treating conditions resulting from the cessation and withdrawal from the use of nicotine
ES2185777T3 (es) Tratamiento de la anorexia.
HUP9902882A2 (hu) Olanzapin alkalmazása álmatlanság kezelésére szolgáló gyógyszerkészítmények előállítására
PL301680A1 (en) Derivatives of 2-thienyl imidazo/2,1-b/benzothiazol-3-acetic acid, their production and application in therapy
MX9700716A (es) 2-aril-5,11-dihidro-6h-dipirido[3,2-b:2',3'-e][1,4] diazepinas y su uso en el tratamiento de la infeccion por vih.